Olutasidenib (FT-2102)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Olutasidenib is a potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 for the treatment of acute myeloid leukemia. |
---|
Catalog Num | A18789 |
---|---|
Formula | C18H15ClN4O2 |
Molecular Weight | 354.79 |
CAS Number | 1887014-12-1 |
SMILES | N#CC1=CC=C(N[C@H](C2=CC3=C(NC2=O)C=CC(Cl)=C3)C)C(N1C)=O |
Synonyms | Olutasidenib; FT-2102; FT 2102; FT2102; |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 70 mg/mL (197.29 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 28.19 mL | 140.93 mL | 281.86 mL |
0.5 mM | 5.64 mL | 28.19 mL | 56.37 mL |
1 mM | 2.82 mL | 14.09 mL | 28.19 mL |
5 mM | 0.56 mL | 2.82 mL | 5.64 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2